Developing a new score system for patients with PSA ranging from 4 to 20 ng/mL to improve the accuracy of PCa detection

To develop a new score system for patients with prostate specific antigen (PSA) ranging from 4 to 20 ng/mL to improve the accuracy of prostate cancer (PCa) detection, and to evaluate it with receiver operatin...

http://ift.tt/2bZEEyL